Autologous Adipose Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
Condition(s):Traumatic Brain InjuryLast Updated:February 28, 2024Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Traumatic Brain InjuryLast Updated:February 28, 2024Enrolling by invitation
Condition(s):Pancreatic CancerLast Updated:July 6, 2021No longer available
Condition(s):Traumatic Brain InjuryLast Updated:June 7, 2023Active, not recruiting
Condition(s):Spinal Cord Injury at C5-C7 LevelLast Updated:July 6, 2021No longer available
Condition(s):Rheumatoid ArthritisLast Updated:March 31, 2022Completed
Condition(s):Congenital Muscular Dystrophy Due to Lamin A/C MutationLast Updated:August 1, 2022No longer available
Condition(s):Parkinson DiseaseLast Updated:November 7, 2023Recruiting
Condition(s):Parkinson DiseaseLast Updated:March 8, 2023Completed
Condition(s):Stroke; Stroke, IschemicLast Updated:November 18, 2022No longer available
Condition(s):System; Lupus ErythematosusLast Updated:May 6, 2023No longer available
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.